Authors: Philip, R Alters, SE Brunette, E Ashton, J Gadea, J Yau, J Lebkowski, J Philip, M

Citation: R. Philip et al., Dendritic cells loaded with MART-1 peptide or infected with adenoviral construct are functionally equivalent in the induction of tumor-specific cytotoxic T lymphocyte responses in patients with melanoma, J IMMUNOTH, 23(1), 2000, pp. 168-176

Authors: Muniappan, A Banapour, B Lebkowski, J Talib, S

Citation: A. Muniappan et al., Ligand-mediated cytolysis of tumor cells: Use of heregulin-zeta chimeras to redirect cytotoxic T lymphocytes, CANC GENE T, 7(1), 2000, pp. 128-134

Authors: Alters, SE Gadea, JR Holm, B Lebkowski, J Philip, R

Citation: Se. Alters et al., IL-13 can substitute for IL-4 in the generation of dendritic cells for theinduction of cytotoxic T lymphocytes and gene therapy, J IMMUNOTH, 22(3), 1999, pp. 229-236

Authors: Gajewski, JL Nimer, S Saliba, RM Thomas, M Przepiorka, D Giralt, S von Besien, K Mehra, R Andersson, B Chan, KW Ippoliti, C Warkinten, D Feig, S Territo, M Schiller, G Lebkowski, J Moseley, AM Lloyd, K von Hoeff, M Okarma, T Champlin, R

Citation: Jl. Gajewski et al., Long-term outcome of a Phase II study of BM transplants, partially depleted ex-vivo of CD5-positive and CD8-positive T-lymphocytes in unrelated and related donor 1 antigen mismatched recipients, CYTOTHERAPY, 1(5), 1999, pp. 401-407